Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride and finasteride affect different cell types differently.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

The structure of SRD5A reveals how it reduces steroids, aiding drug design for related health conditions.

Adding a second method to PROTACs could improve cancer treatment.

Bicalutamide may help treat female pattern hair loss.

A group has developed therapies that show promise for treating cancer and various other conditions.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

Vitamin D has potential benefits for cancer prevention, heart health, diabetes, obesity, muscle function, skin health, and immune function, but clinical results are mixed and more research is needed.

Drugs for hormone-related conditions might help treat mental disorders but could have serious side effects.

Epigenetic changes control how adult stem cells work and can lead to diseases like cancer if they go wrong.

Avicennia Marina extract and avicequinone C can reduce hair loss hormone production and increase hair growth factors, suggesting they could be used to treat androgenic alopecia.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

The document concludes that early diagnosis and treatment of Congenital Adrenal Hyperplasia are crucial for preventing serious health issues and improving patient outcomes.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Colorectal cancer development involves both genetic changes and epigenetic alterations like DNA methylation and microRNA changes.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

The same hormone can affect gene expression differently in various tissues, which could lead to new treatments for conditions like hair loss.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Finasteride, a hair loss drug, may cause long-term sexual side effects due to changes in hormone receptor levels.

The Wnt/β-catenin pathway is important for body functions and diseases, and targeting it may treat conditions like cancer, but with safety challenges.

Dihydrotestosterone makes arteries stiffer in female mice by reducing estrogen receptor expression.